HIMS STOCK IS CRASHING! Here's Why:
1 extracted signal · 1 resolved · 0 still active
The Patient Investor11 May 2026, 21:48 UTC
AI-generated source summary
The stock HIMS experienced a significant drop of 10% in after-hours trading following its earnings report. While subscriber growth was strong at 20%, revenue growth was only 4%, which is considered weak for a growing company. The presenter highlights that international revenue is growing approximately 10x year-over-year, driven by an acquisition in Australia and Japan, contributing to a 25-28% revenue growth forecast for Q2 2026 and 19-28% for FY 2026. Adjusted EBITDA margins are expected to recover from 7% to 11% by FY 2026. However, the recent earnings report and the decline in stock price suggest that the market may be reacting negatively to the company's guidance or performance in key areas, potentially due to increased marketing spend for international expansion and the company's prior divestiture of certain assets. The price-to-sales ratio is noted at 2.72, which is considered low, suggesting the stock might be undervalued given its growth potential and market expansion strategy.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Signals in this source
More Prediction Case Files from The Patient Investor
Why I Don't Own Google Stock & When I'm Buying
The CHEAPEST Quality Stock In The Stock Market!
Intuitive Surgical Stock Analysis! Risks & Upside Potential
There Is NO AI BUBBLE! I’m Buying Every Dip
2 Stocks I'm Buying In The Next 2 Weeks
Netflix Stock Is FINALLY A Buy!
The Patient Investor
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
